Article
How to read a next-generation sequencing report—what oncologists need to know
29 Sept 2022
Abstract excerpt
Next-generation sequencing (NGS) of tumor cell-derived DNA/RNA to screen for targetable genomic alterations is now widely available and has become part of routine practice in oncology. NGS testing strategies depend on cancer type, disease stage and the impact of results on treatment selection. The European Society for Medical Oncology (ESMO) has recently published recommendations for the use of NGS in patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
